<DOC>
	<DOCNO>NCT02807610</DOCNO>
	<brief_summary>The ideal induction agent day care surgery property rapid , smooth induction , good haemodynamic profile , fast recovery devoid side effect form pain injection , involuntary movement , respiratory depression post-operative nausea/vomiting . Propofol drug use day care surgery rapid , smooth induction faster recovery . But use associated pain injection ( even add lidocaine ) , hypotension respiratory depression . So need agent well hemodynamic control lesser side effect felt . The introduction etomidate lipuro revolutionise anaesthesia practice . It possess many property ideal induction agent . This new formulation etomidate lipid emulsion i.e . etomidate lipuro know rapid , smooth induction , haemodynamic stability lesser side effect older etomidate propylene glycol ( hypnomidate ) . Hence , investigator devise prospective randomize control open trial compare new lipid formulation etomidate propofol term - induction time , haemodynamic parameter side effect profile .</brief_summary>
	<brief_title>Etomidate vs Propofol-Induction Characteristics</brief_title>
	<detailed_description>The administration suitable drug intravenous route induction anaesthesia important component anaesthetic management.The ability deliver safe effective anaesthesia minimal side effect rapid recovery critically important ensure safe early discharge . An ideal intravenous ( IV ) anaesthetic agent , rapid onset , rapid recovery , without undesirable cardiac respiratory depression lesser untoward effect like pain injection , nausea , vomit etc.No single drug ideal . Propofol ( propofol 1 % ) smooth rapid induction , rapid recovery , cerebro-protective effect cause hypotension , bradycardia , respiratory depression pain injection.Etomidate hypnotic agent cause minimal histamine release stable hemodynamic profile . In present study , investigator evaluate induction characteristic side effect profile newer lipid formulation etomidate compare propofol lipid formulation . Material Methods : Hundred ASA I &amp; II patient age group 18-60 yr , schedule dilatation curettage procedure randomly allocate two group base induction agent Etomidate lipuro Propofol . Both group receive intravenous midazolam 0.02mg /kg fentanyl 2 Âµg /kg premedication . After induction desire agent titrate bispectral index Entropy 40 , time achieve BIS value 40 ( BIS 40 time ) measure . Heart rate , mean arterial pressure record baseline , induction upto 10 minute . Patients ask pain injection site , postoperative nausea observe visually myoclonus , apnea thrombophlebitis .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Etomidate</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>ASA I II Female patient Elective Medical Termination Pregnancy ( MTP ) surgery Hemodynamically unstable patient Allergic egg protein Patients epilepsy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Etomidate lipuro</keyword>
	<keyword>Induction characteristic</keyword>
</DOC>